These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Management of patients with decompensated hepatitis B virus associated [corrected] cirrhosis. Zoulim F; Radenne S; Ducerf C Liver Transpl; 2008 Oct; 14 Suppl 2():S1-7. PubMed ID: 18825719 [TBL] [Abstract][Full Text] [Related]
30. Therapy of hepatitis C: patients with cirrhosis. Schalm SW; Fattovich G; Brouwer JT Hepatology; 1997 Sep; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677 [TBL] [Abstract][Full Text] [Related]
31. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C. Colletta C; Smirne C; Marini C; Pirisi M J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600 [No Abstract] [Full Text] [Related]
32. [Antiviral treatment for hepatitis B virus related liver cirrhosis]. Xie Q; Gui HL Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):837-8. PubMed ID: 17125614 [No Abstract] [Full Text] [Related]
33. Treatment of hepatitis C in the patient with decompensated cirrhosis. Everson GT Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S106-12. PubMed ID: 16234056 [TBL] [Abstract][Full Text] [Related]
34. Treatment of HBV-related cirrhosis. Vallet-Pichard A; Mallet V; Costentin CE; Pol S Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793 [TBL] [Abstract][Full Text] [Related]
35. Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis. Tseng PL; Lu SN; Tung HD; Wang JH; Changchien CS; Lee CM J Viral Hepat; 2005 Jul; 12(4):386-92. PubMed ID: 15985009 [TBL] [Abstract][Full Text] [Related]
36. [The course of hepatitis C infection after liver transplantation]. Ołdakowska-Jedynak U; Paczek L Pol Merkur Lekarski; 2005 Aug; 19(110):220-4. PubMed ID: 16245439 [TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis. Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845 [TBL] [Abstract][Full Text] [Related]
38. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?]. Brenard R; Closon ML; Fevery J; Hautekeete M Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538 [No Abstract] [Full Text] [Related]
39. Histologic improvement of fibrosis in patients with hepatitis C and sustained response to interferon therapy. Bolaños-Meade J; López-Arvizu C Ann Intern Med; 2000 Aug; 133(4):312. PubMed ID: 10929184 [No Abstract] [Full Text] [Related]
40. Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C. Khokhar N; Niazi TK; Qureshi MO J Coll Physicians Surg Pak; 2013 Oct; 23(10):699-702. PubMed ID: 24112253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]